Technical Analysis for XGN - Exagen Inc.

Grade Last Price % Change Price Change
grade B 17.97 2.45% 0.43
XGN closed up 2.45 percent on Friday, December 13, 2019, on 63 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Flat
See historical XGN trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
20 DMA Resistance Bearish 2.45%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.45%
Pocket Pivot Bullish Swing Setup 2.45%
Inside Day Range Contraction 2.45%
20 DMA Resistance Bearish 2.57%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.57%
Inside Day Range Contraction 2.57%
20 DMA Resistance Bearish -0.11%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.11%
Older signals for XGN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Exagen Inc. operates as a commercial-stage diagnostics company, develops and markets products for the diagnosis, prognosis, and monitoring of patients affected by autoimmune rheumatic diseases (ARDs). Its lead product includes Avise SLE+CT, a proprietary diagnostic test that provides an enhanced solution for patients with a range of ARDs, such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Sjögren's syndrome, and scleroderma, as well as other disorders, including fibromyalgia. The company also offers Avise SLE Prognostic, a blood test that complements Avise SLE+CT; Avise MTX, a therapeutic drug monitoring test to measure levels of methotrexate polyglutamates; and Avise HCQ, a blood test for physicians to monitor blood levels of HCQ. In addition, it is developing Anti-TNF, a blood test to monitor the levels of anti-TNF bioactivity in patients with RA; Avise SLE Monitoring, a multi-analyte panel blood test for physicians to track the disease status of their SLE patients; and Avise RA, a blood test to determine bone damage or joint erosion. The company primarily serves rheumatologists in the United States. It was formerly known as Exagen Diagnostics, Inc. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.
Medicine Medical Specialties Clinical Medicine Immunology Disease Autoimmune Diseases Disorders Rheumatoid Arthritis Autoimmunity Rheumatology Fibromyalgia Scleroderma Sjögren's Syndrome Sle Systemic Lupus Erythematosus

Is XGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 21.41
52 Week Low 11.54
Average Volume 61,116
200-Day Moving Average 0.00
50-Day Moving Average 16.64
20-Day Moving Average 18.13
10-Day Moving Average 17.91
Average True Range 1.37
ADX 16.0
+DI 14.65
-DI 11.57
Chandelier Exit (Long, 3 ATRs ) 17.30
Chandelier Exit (Short, 3 ATRs ) 20.42
Upper Bollinger Band 19.44
Lower Bollinger Band 16.82
Percent B (%b) 0.44
BandWidth 14.49
MACD Line 0.13
MACD Signal Line 0.26
MACD Histogram -0.1339
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.26
Resistance 3 (R3) 19.26 18.83 19.04
Resistance 2 (R2) 18.83 18.50 18.83 18.97
Resistance 1 (R1) 18.40 18.30 18.61 18.40 18.90
Pivot Point 17.97 17.97 18.08 17.97 17.97
Support 1 (S1) 17.54 17.64 17.76 17.54 17.04
Support 2 (S2) 17.11 17.44 17.11 16.97
Support 3 (S3) 16.68 17.11 16.90
Support 4 (S4) 16.68